← 產業報告目錄

Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-11-20頁數 589報告編號 BT2209

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, exhibiting a CAGR of 12.6% from 2025 to 2030. The genomics market is experiencing strong growth, driven by increasing government funding, the rising prevalence of viral and hereditary diseases, and ongoing advancements in next-generation sequencing (NGS) technologies. Beyond traditional applications in genetic disorder identification and drug discovery, genomics is gaining traction in agriculture, veterinary science, and forensics. In forensics, the adoption of NGS has revolutionized DNA analysis. Traditional DNA fingerprinting methods are being replaced by comprehensive genomic reconstruction, enabling more precise identification. NGS also facilitates on-site analysis, allowing the extraction of detailed genetic information from trace or degraded DNA samples, thereby enhancing the accuracy and scope of forensic investigations. “The reagents, kits, and consumables segment is projected to record the highest CAGR during the forecast period.” Based on product type, the genomics market is segmented into reagents, kits, and consumables; instruments; and bioinformatics tools. The reagents, kits, and consumables segment accounted for the largest share of the product market. Reagents and kits are essential for nearly all genomic workflows, including DNA and RNA extraction, amplification, sequencing, and analysis. They are vital for both research and clinical applications. The demand for these products is driven by the increasing number of genomic experiments conducted in diagnostics, personalized medicine, and drug development. Each workflow requires a consistent supply of high-quality reagents and kits to ensure the accurate and reliable generation of genomic data. Moreover, the rapid adoption of advanced technologies such as next-generation sequencing (NGS) and polymerase chain reaction (PCR) further increases the need for application-specific reagents and consumables. The ongoing growth in genomics sectors, such as healthcare, research, and biotechnology, enhances the revenue generated from consumables, solidifying its leading market position. “The hospitals, diagnostic laboratories, and clinics segment accounted for the largest share in 2024.” In 2024, the hospitals, diagnostic laboratories, and clinics segment accounted for the largest share of the global genomic products market. The large share of this end-user segment can be attributed to increased patient engagement in genomic research, driven by citizen science initiatives. These efforts aim to democratize data collection and accelerate discoveries in rare diseases and personalized medicine. Additionally, pharmaceutical & biotechnology companies hold the second-largest share in this segment. “The US dominated the North American genomics market in 2024.” The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for genomics products & services is expected to grow over the coming years, driven by its advanced research ecosystem, strong funding support, and presence of major industry leaders such as Illumina, Thermo Fisher Scientific, Agilent Technologies, and Danaher. The country benefits from substantial government and private investments in precision medicine and population genomics programs, including NIH and All of Us initiatives. High adoption of next-generation sequencing (NGS) and bioinformatics platforms across clinical and research settings further supports market leadership. Additionally, a well-established regulatory framework, robust healthcare infrastructure, and active public–private collaborations foster continuous innovation and commercialization of genomic technologies in the US. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side (70%) and Demand Side (30%) • By Designation: Managers (45%), CXOs & Directors (30%), and Executives (25%) • By Region: North America (40%), Europe (25%), Asia Pacific (25%), Latin America (5%), and the Middle East & Africa (5%) Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US) are some of the key players operating in the genomics market. Research Coverage: This research report categorizes the genomics market by offering {products [type (reagents, kits, and consumables; instruments; and bioinformatics tools), technology (sequencing, PCR, gene editing, flow cytometry, microarrays, in situ hybridization, and other technologies), and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; CROs; and other end users)] and services [type (genomics profiling and sequencing services, sample preparation and library preparation services, and bioinformatics services) and end user (hospitals, diagnostic laboratories, and clinics; academic & research institutes; pharmaceutical & biotechnology companies; and other end users)]}, application (drug discovery & development, diagnostics, agriculture and animal research, and other applications), study type (functional genomics, biomarker discovery, pathway analysis, epigenomics, and other study types), and region (North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa). The report’s scope encompasses detailed information regarding the key factors, including drivers, restraints, challenges, and opportunities, that influence market growth. A thorough analysis of key industry players has provided insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations, and acquisitions are recent developments in the genomics market. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall genomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights into the following pointers: • Analysis of key drivers (increasing government funding for genomics projects, increasing prevalence of viral and inherited disorders, advancements in NGS platforms, and growing applications of genomics), restraints (high investment costs), opportunities (increasing use of genomics in precision medicine and technological advancements in genomics), and challenges (handling of large volume of data sets and their analysis and clinical utility of genomics) influencing the growth of the market. • Product Development/Innovation: Detailed insights on newly launched products/services of the genomics market. • Market Development: Comprehensive information about lucrative markets; the report analyzes the market across varied regions. • Market Diversification: Exhaustive information about new products/services, untapped geographies, recent developments, and investments in the genomics market. • Competitive Assessment: Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Germany), Agilent Technologies, Inc. (US), Revvity (US), Laboratory Corporation of America Holdings (US), and IQVIA Inc. (US), among others in the market.
目錄 Table of Contents
1 INTRODUCTION 44 1.1 STUDY OBJECTIVES 44 1.2 MARKET DEFINITION 44 1.3 STUDY SCOPE 44 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 45 1.3.2 INCLUSIONS AND EXCLUSIONS 46 1.3.3 YEARS CONSIDERED 47 1.3.4 CURRENCY CONSIDERED 47 1.3.5 UNITS CONSIDERED 47 1.4 STAKEHOLDERS 47 1.5 SUMMARY OF CHANGES 48 2 RESEARCH METHODOLOGY 49 2.1 RESEARCH DATA 49 2.1.1 SECONDARY DATA 50 2.1.1.1 Key objectives of secondary research 50 2.1.2 PRIMARY DATA 51 2.1.2.1 Breakdown of primaries 51 2.1.2.2 Key objectives of primary research 52 2.2 MARKET SIZE ESTIMATION 52 2.2.1 GLOBAL GENOMICS MARKET ESTIMATION, 2024 52 2.2.1.1 Company revenue analysis (bottom-up approach) 53 2.2.1.2 MNM repository analysis 54 2.2.1.3 Primary research 54 2.2.2 SEGMENTAL MARKET SIZE ESTIMATION (TOP–DOWN APPROACH) 55 2.3 MARKET GROWTH RATE PROJECTIONS 58 2.4 DATA TRIANGULATION 60 2.5 STUDY ASSUMPTIONS 61 2.6 RESEARCH LIMITATIONS 62 2.7 RISK ANALYSIS 62 3 EXECUTIVE SUMMARY 63 3.1 KEY INSIGHTS & MARKET HIGHLIGHTS 63 3.2 KEY MARKET PARTICIPANTS: INSIGHTS AND STRATEGIC DEVELOPMENTS 69 3.3 DISRUPTIVE TRENDS SHAPING GENOMICS MARKET 70 3.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 70   4 PREMIUM INSIGHTS 71 4.1 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 71 4.2 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION AND COUNTRY, 2024 72 4.3 GENOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 73 5 MARKET OVERVIEW 74 5.1 INTRODUCTION 74 5.2 MARKET DYNAMICS 74 5.2.1 DRIVERS 75 5.2.1.1 Increasing government funding for genomics projects 75 5.2.1.2 Increasing prevalence of viral and inherited disorders 76 5.2.1.3 Advancements in NGS platforms 77 5.2.1.4 Growing applications of genomics 78 5.2.2 RESTRAINTS 79 5.2.2.1 High investment costs 79 5.2.3 OPPORTUNITIES 79 5.2.3.1 Increasing use of genomics in precision medicine 79 5.2.3.2 Technological advancements in genomics 80 5.2.4 CHALLENGES 81 5.2.4.1 Handling large volumes of data sets and their analysis 81 5.2.4.2 Clinical utility of genomics 81 5.3 UNMET NEEDS AND WHITE SPACES 82 5.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 82 5.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 83 6 INDUSTRY TRENDS 84 6.1 PORTER’S FIVE FORCES ANALYSIS 84 6.1.1 INTENSITY OF COMPETITIVE RIVALRY 85 6.1.2 BARGAINING POWER OF SUPPLIERS 85 6.1.3 BARGAINING POWER OF BUYERS 85 6.1.4 THREAT OF SUBSTITUTES 85 6.1.5 THREAT OF NEW ENTRANTS 86 6.2 MACROECONOMIC OUTLOOK 86 6.2.1 INTRODUCTION 86 6.2.2 GDP TRENDS AND FORECAST 86 6.2.3 TRENDS IN GLOBAL GENOMICS INDUSTRY 87 6.3 VALUE CHAIN ANALYSIS 87 6.4 ECOSYSTEM ANALYSIS 89 6.4.1 EMERGING BUSINESS MODELS & ECOSYSTEM SHIFTS 90   6.5 PRICING ANALYSIS 91 6.5.1 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 92 6.5.2 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 93 6.5.3 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 94 6.5.4 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024 95 6.6 TRADE ANALYSIS 96 6.6.1 IMPORT SCENARIO (HS CODE 3822 & 902789) 96 6.6.2 EXPORT SCENARIO (HS CODE 3822 & 902789) 99 6.7 KEY CONFERENCES AND EVENTS, 2026 102 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103 6.9 INVESTMENT AND FUNDING SCENARIO 104 6.9.1 VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE 105 6.10 CASE STUDY ANALYSIS 106 6.11 IMPACT OF 2025 US TARIFFS—GENOMICS MARKET 107 6.11.1 INTRODUCTION 107 6.11.2 KEY TARIFF RATES 108 6.11.3 PRICE IMPACT ANALYSIS 109 6.11.4 IMPACT ON COUNTRIES/REGIONS 109 6.11.4.1 US 109 6.11.4.2 Europe 109 6.11.4.3 Asia Pacific 110 6.11.5 IMPACT ON END-USE INDUSTRIES 110 6.11.5.1 Pharmaceutical & biotechnology companies 110 6.11.5.2 CROs and academic & research institutes 111 6.11.5.3 Hospitals, diagnostic laboratories, and clinics 111 7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 112 7.1 TECHNOLOGICAL ANALYSIS 112 7.1.1 KEY EMERGING TECHNOLOGIES 112 7.1.1.1 Sequencing by synthesis 112 7.1.1.2 Single-molecule real-time sequencing 112 7.1.1.3 Nanopore sequencing 113 7.1.1.4 qPCR 113 7.1.1.5 dPCR 114 7.1.1.6 Microarray technology 114 7.1.2 COMPLEMENTARY TECHNOLOGIES 114 7.1.2.1 Cytogenetics 114 7.1.2.2 Synthetic biology 115 7.1.2.3 Multiomics 115 7.1.2.4 Single-cell analysis 115 7.1.3 ADJACENT TECHNOLOGIES 116 7.1.3.1 Bioinformatics and computational biology 116 7.1.3.2 Artificial intelligence and machine learning 116 7.2 TECHNOLOGY/PRODUCT ROADMAP 117 7.3 PATENT ANALYSIS 117 7.3.1 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024 118 7.4 FUTURE APPLICATIONS 120 7.5 IMPACT OF AI/GEN AI ON GENOMICS MARKET 121 7.5.1 BEST PRACTICES IN GENOMICS WORKFLOW 122 7.5.2 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET 123 7.5.3 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 123 7.5.4 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN GENOMICS MARKET 123 8 SUSTAINABILITY AND REGULATORY LANDSCAPE 125 8.1 REGIONAL REGULATIONS AND COMPLIANCE 125 8.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 125 8.1.2 INDUSTRY STANDARDS 127 8.2 SUSTAINABILITY INITIATIVES 129 8.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES 129 8.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 130 9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 132 9.1 DECISION-MAKING PROCESS 132 9.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 132 9.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 132 9.2.2 KEY BUYING CRITERIA, BY END USER 133 9.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 134 9.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 134 9.5 MARKET PROFITABILITY 135 10 GENOMICS MARKET, BY OFFERING 136 10.1 INTRODUCTION 137 10.2 PRODUCTS 137 10.2.1 ACCELERATION OF HIGH-THROUGHPUT GENOMICS DRIVEN BY PLATFORM INNOVATION AND AUTOMATION IS BOOSTING GROWTH 137 10.3 SERVICES 140 10.3.1 RAPID EXPANSION OF GENOMIC SERVICES FUELED BY CLINICAL ADOPTION AND DATA-DRIVEN DECISION SUPPORT 140   11 GENOMICS PRODUCTS MARKET, BY TYPE 144 11.1 INTRODUCTION 145 11.2 REAGENTS, KITS, AND CONSUMABLES 145 11.2.1 LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE PROPEL DEMAND FOR REAGENTS, KITS, AND CONSUMABLES 145 11.3 INSTRUMENTS 150 11.3.1 TECHNOLOGICAL ADVANCEMENTS TO SUPPORT MARKET GROWTH 150 11.4 BIOINFORMATICS TOOLS 154 11.4.1 ACCELERATING GENOMIC INSIGHTS THROUGH SCALABLE, AI-ENABLED BIOINFORMATICS PLATFORMS DRIVE MARKET GROWTH 154 12 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY 158 12.1 INTRODUCTION 159 12.2 SEQUENCING 159 12.2.1 DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH 159 12.3 PCR 163 12.3.1 RISING DEMAND FOR BIOMARKER DISCOVERY TO PROPEL MARKET GROWTH 163 12.4 GENE EDITING 167 12.4.1 RISING DEMAND FOR NEWER THERAPEUTIC APPROACHES DRIVING GROWTH 167 12.5 FLOW CYTOMETRY 170 12.5.1 RISING DEMAND FOR FLOW CYTOMETRY IN AGRIGENOMICS TO DRIVE MARKET GROWTH 170 12.6 MICROARRAYS 174 12.6.1 RISING ADOPTION OF HIGH-THROUGHPUT TECHNOLOGIES LIMITING MARKET GROWTH 174 12.7 IN SITU HYBRIDIZATION 178 12.7.1 INCREASING DEMAND FOR PRECISE GENE EXPRESSION ANALYSIS DRIVING GROWTH 178 12.8 OTHER TECHNOLOGIES 182 13 GENOMICS PRODUCTS MARKET, BY END USER 186 13.1 INTRODUCTION 187 13.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS 187 13.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 187 13.3 ACADEMIC & RESEARCH INSTITUTES 192 13.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 192 13.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 196 13.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS PROPELS MARKET 196 13.5 CROS 200 13.5.1 RISING COLLABORATION BETWEEN PHARMA COMPANIES AND CROS DRIVING MARKET GROWTH 200 13.6 OTHER END USERS 204 14 GENOMICS SERVICES MARKET, BY TYPE 207 14.1 INTRODUCTION 208 14.2 GENOMIC PROFILING & SEQUENCING SERVICES 208 14.2.1 INCREASED ADOPTION OF SEQUENCING TECHNOLOGIES IN CLINICAL ADOPTION TO SUPPORT MARKET GROWTH 208 14.3 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES 212 14.3.1 INCREASED DEMAND FOR ONCOLOGY AND RARE DISEASE DIAGNOSTICS TO DRIVE MARKET GROWTH 212 14.4 BIOINFORMATICS SERVICES 215 14.4.1 RISING DEMAND FOR ADVANCED PERSONALIZED MEDICINE TO SUPPORT MARKET GROWTH 215 15 GENOMICS SERVICES MARKET, BY END USER 219 15.1 INTRODUCTION 220 15.2 HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS 220 15.2.1 INCREASED APPLICATION IN DISEASE DIAGNOSTICS AND TREATMENT DRIVING MARKET GROWTH 220 15.3 ACADEMIC & RESEARCH INSTITUTES 224 15.3.1 RISING RESEARCH INTENSITY FOR GENOMICS RESEARCH AMONG INSTITUTES TO SUPPORT MARKET GROWTH 224 15.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 227 15.4.1 RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO DRIVE GROWTH 227 15.5 OTHER END USERS 231 16 GENOMICS MARKET, BY APPLICATION 235 16.1 INTRODUCTION 236 16.2 DRUG DISCOVERY & DEVELOPMENT 236 16.2.1 DRUG DISCOVERY & DEVELOPMENT TO BE LARGEST APPLICATION IN GENOMICS MARKET 236 16.3 DIAGNOSTICS 240 16.3.1 CANCER DIAGNOSTICS 243 16.3.1.1 Rising demand for targeted therapies to drive market growth 243 16.3.2 INFECTIOUS DISEASES 248 16.3.2.1 Rising demand for comprehensive genomic data in clinical genomics to drive market growth 248 16.3.3 REPRODUCTIVE HEALTH 251 16.3.3.1 Rising focus on genetic diseases to drive market growth 251 16.3.4 OTHER DIAGNOSTIC APPLICATIONS 255   16.4 AGRICULTURE & ANIMAL RESEARCH 258 16.4.1 GENOMICS TO HELP IMPROVE CROP PRODUCTIVITY 258 16.5 OTHER APPLICATIONS 261 17 GENOMICS MARKET, BY STUDY TYPE 265 17.1 INTRODUCTION 266 17.2 FUNCTIONAL GENOMICS 266 17.2.1 INCREASED FOCUS ON FUNCTIONAL GENOME STUDIES TO DRIVE MARKET GROWTH 266 17.3 BIOMARKER DISCOVERY 270 17.3.1 RISING DEMAND FOR PRECISION MEDICINE TO SUPPORT MARKET GROWTH 270 17.4 PATHWAY ANALYSIS 273 17.4.1 RISING PREVALENCE OF COMPLEX DISEASES TO AUGMENT MARKET GROWTH 273 17.5 EPIGENOMICS 277 17.5.1 RISING INVESTMENTS FOR EPIGENETICS RESEARCH TO BOOST MARKET GROWTH 277 17.6 OTHER STUDY TYPES 281 18 GENOMICS MARKET, BY REGION 285 18.1 INTRODUCTION 286 18.2 NORTH AMERICA 286 18.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 287 18.2.2 US 292 18.2.2.1 US expected to dominate market in North America 292 18.2.3 CANADA 298 18.2.3.1 Increasing government initiatives in genomics research to boost market growth 298 18.3 EUROPE 302 18.3.1 EUROPE: MACROECONOMIC OUTLOOK 303 18.3.2 GERMANY 308 18.3.2.1 Germany to dominate European genomics market 308 18.3.3 UK 313 18.3.3.1 Strategic initiatives and funding for genomics research to support market growth 313 18.3.4 FRANCE 318 18.3.4.1 Increasing government investment in genomics research to drive growth 318 18.3.5 ITALY 322 18.3.5.1 Favorable funding scenario to drive adoption of advanced sequencing technology 322 18.3.6 SPAIN 327 18.3.6.1 Growing focus on advancements in personalized medicine to support market growth 327 18.3.7 REST OF EUROPE 332 18.4 ASIA PACIFIC 337 18.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 338 18.4.2 CHINA 343 18.4.2.1 China to dominate Asia Pacific market during forecast period 343 18.4.3 JAPAN 348 18.4.3.1 Rising number of collaborations in genomics to drive market 348 18.4.4 INDIA 352 18.4.4.1 Government and private initiatives for genomics to propel market 352 18.4.5 AUSTRALIA 357 18.4.5.1 Increased genomics research in Australia to support market growth 357 18.4.6 SOUTH KOREA 361 18.4.6.1 Demand for advanced sequencing technologies to support market growth in South Korea 361 18.4.7 REST OF ASIA PACIFIC 366 18.5 LATIN AMERICA 371 18.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 371 18.5.2 BRAZIL 376 18.5.2.1 Increased government investments in genomics advancements to drive market in Brazil 376 18.5.3 MEXICO 381 18.5.3.1 Rising demand for chronic disease treatment to support market growth in Mexico 381 18.5.4 REST OF LATIN AMERICA 385 18.6 MIDDLE EAST 390 18.6.1 MIDDLE EAST: MACROECONOMIC OUTLOOK 390 18.6.2 GCC COUNTRIES 395 18.6.2.1 Saudi Arabia 400 18.6.2.1.1 Growing healthcare expenditure in Saudi Arabia to boost market growth 400 18.6.2.2 United Arab Emirates 404 18.6.2.2.1 Growing collaborations to advance genome sequencing to aid market growth in UAE 404 18.6.2.3 Rest of GCC Countries 409 18.6.3 REST OF MIDDLE EAST 414 18.7 AFRICA 418 18.7.1 GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET IN AFRICA 418 18.7.2 AFRICA: MACROECONOMIC OUTLOOK 419 19 COMPETITIVE LANDSCAPE 424 19.1 INTRODUCTION 424 19.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 424 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN GENOMICS MARKET 425   19.3 REVENUE ANALYSIS, 2020–2024 426 19.4 MARKET SHARE ANALYSIS, 2024 427 19.5 BRAND/PRODUCT COMPARISON 430 19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 431 19.6.1 STARS 431 19.6.2 EMERGING LEADERS 431 19.6.3 PERVASIVE PLAYERS 431 19.6.4 PARTICIPANTS 431 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 433 19.6.5.1 Company footprint 433 19.6.5.2 Region footprint 434 19.6.5.3 Product footprint 435 19.6.5.4 Application footprint 436 19.6.5.5 Technology footprint 437 19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 438 19.7.1 PROGRESSIVE COMPANIES 438 19.7.2 RESPONSIVE COMPANIES 438 19.7.3 DYNAMIC COMPANIES 438 19.7.4 STARTING BLOCKS 438 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 440 19.7.5.1 Detailed list of key startups/SMEs 440 19.7.5.2 Competitive benchmarking of key startups/SMEs 440 19.8 COMPANY VALUATION & FINANCIAL METRICS 441 19.8.1 FINANCIAL METRICS 441 19.8.2 COMPANY VALUATION 441 19.9 COMPETITIVE SCENARIO 442 19.9.1 PRODUCT LAUNCHES 442 19.9.2 DEALS 443 19.9.3 EXPANSIONS 443 20 COMPANY PROFILES 445 20.1 INTRODUCTION 445 20.2 KEY PLAYERS 445 20.2.1 THERMO FISHER SCIENTIFIC INC. 445 20.2.1.1 Business overview 445 20.2.1.2 Products/Services offered 446 20.2.1.3 Recent developments 451 20.2.1.3.1 Product launches and approvals 451 20.2.1.3.2 Deals 454 20.2.1.3.3 Expansions 455   20.2.1.4 MnM view 455 20.2.1.4.1 Key strengths 455 20.2.1.4.2 Strategic choices 456 20.2.1.4.3 Weaknesses and competitive threats 456 20.2.2 ILLUMINA, INC. 457 20.2.2.1 Business overview 457 20.2.2.2 Products/Services offered 458 20.2.2.3 Recent developments 461 20.2.2.3.1 Product launches and approvals 461 20.2.2.3.2 Deals 463 20.2.2.3.3 Expansions 465 20.2.2.3.4 Other developments 465 20.2.2.4 MnM view 466 20.2.2.4.1 Key strengths 466 20.2.2.4.2 Strategic choices 466 20.2.2.4.3 Weaknesses and competitive threats 466 20.2.3 DANAHER CORPORATION 467 20.2.3.1 Business overview 467 20.2.3.2 Products/Services offered 468 20.2.3.3 Recent developments 470 20.2.3.3.1 Product launches 470 20.2.3.3.2 Deals 471 20.2.3.3.3 Expansions 472 20.2.3.4 MnM view 473 20.2.3.4.1 Key strengths 473 20.2.3.4.2 Strategic choices 473 20.2.3.4.3 Weaknesses and competitive threats 473 20.2.4 F. HOFFMANN-LA ROCHE LTD. 474 20.2.4.1 Business overview 474 20.2.4.2 Products/Services offered 475 20.2.4.2.1 Product launches 477 20.2.4.2.2 Deals 478 20.2.4.2.3 Other developments 479 20.2.4.3 MnM view 479 20.2.4.3.1 Key strengths 479 20.2.4.3.2 Strategic choices 479 20.2.4.3.3 Weaknesses and competitive threats 479 20.2.5 AGILENT TECHNOLOGIES, INC. 480 20.2.5.1 Business overview 480 20.2.5.2 Products/Services offered 481 20.2.5.3 Recent developments 484 20.2.5.3.1 Product launches 484 20.2.5.3.2 Deals 485 20.2.5.3.3 Expansions 486 20.2.5.4 MnM view 487 20.2.5.4.1 Key strengths 487 20.2.5.4.2 Strategic choices 487 20.2.5.4.3 Weaknesses and competitive threats 487 20.2.6 QIAGEN 488 20.2.6.1 Business overview 488 20.2.6.2 Products/Services offered 489 20.2.6.3 Recent developments 492 20.2.6.3.1 Product launches and approvals 492 20.2.6.3.2 Deals 493 20.2.6.3.3 Expansions 495 20.2.7 REVVITY 496 20.2.7.1 Business overview 496 20.2.7.2 Products/Services offered 497 20.2.7.3 Recent developments 500 20.2.7.3.1 Product launches 500 20.2.7.3.2 Deals 501 20.2.7.3.3 Expansions 501 20.2.8 LABORATORY CORPORATION OF AMERICA HOLDINGS 502 20.2.8.1 Business overview 502 20.2.8.2 Services offered 503 20.2.8.3 Recent developments 504 20.2.8.3.1 Service launches 504 20.2.8.3.2 Deals 505 20.2.8.3.3 Expansions 505 20.2.9 IQVIA INC. 506 20.2.9.1 Business overview 506 20.2.9.2 Services offered 507 20.2.9.3 Recent developments 508 20.2.9.3.1 Deals 508 20.2.10 CHARLES RIVER LABORATORIES 509 20.2.10.1 Business overview 509 20.2.10.2 Services offered 510 20.2.11 BIO-RAD LABORATORIES, INC. 511 20.2.11.1 Business overview 511 20.2.11.2 Products/Services offered 512 20.2.11.3 Recent developments 514 20.2.11.3.1 Product launches and approvals 514 20.2.11.3.2 Deals 515   20.2.12 EUROFINS SCIENTIFIC 516 20.2.12.1 Business overview 516 20.2.12.2 Products/Services offered 517 20.2.12.3 Recent developments 518 20.2.12.3.1 Product launches 518 20.2.12.3.2 Deals 518 20.2.13 PACBIO 519 20.2.13.1 Business overview 519 20.2.13.2 Products/Services offered 520 20.2.13.3 Recent developments 522 20.2.13.3.1 Product launches 522 20.2.13.3.2 Deals 523 20.2.13.3.3 Expansions 525 20.2.13.3.4 Other developments 525 20.2.14 OXFORD NANOPORE TECHNOLOGIES PLC. 526 20.2.14.1 Business overview 526 20.2.14.2 Products/Services offered 527 20.2.14.3 Recent developments 529 20.2.14.3.1 Product launches 529 20.2.14.3.2 Deals 529 20.2.14.3.3 Expansions 532 20.2.15 TAKARA BIO INC. 533 20.2.15.1 Business overview 533 20.2.15.2 Products/Services offered 534 20.2.15.3 Recent developments 538 20.2.15.3.1 Product launches 538 20.2.15.3.2 Deals 538 20.2.16 BGI GROUP 539 20.2.16.1 Business overview 539 20.2.16.2 Products/Services offered 539 20.2.16.3 Recent developments 543 20.2.16.3.1 Product & service launches and approvals 543 20.2.16.3.2 Deals 544 20.2.16.3.3 Other developments 545 20.2.17 EPPENDORF SE 546 20.2.17.1 Business overview 546 20.2.17.2 Products/Services offered 547 20.2.17.3 Recent developments 548 20.2.17.3.1 Product launches 548   20.2.18 MERCK KGAA 549 20.2.18.1 Business overview 549 20.2.18.2 Products/Services offered 550 20.2.18.3 Recent developments 551 20.2.18.3.1 Deals 551 20.2.18.3.2 Expansions 552 20.2.19 BD 553 20.2.19.1 Business overview 553 20.2.19.2 Products/Services offered 554 20.2.19.3 Recent developments 556 20.2.19.3.1 Product launches and approvals 556 20.2.19.3.2 Deals 557 20.2.20 ABBOTT 558 20.2.20.1 Business overview 558 20.2.20.2 Products/Services offered 559 20.2.21 10X GENOMICS 562 20.2.21.1 Business overview 562 20.2.21.2 Products/Services offered 563 20.2.21.3 Recent developments 565 20.2.21.3.1 Product launches 565 20.2.22 NEW ENGLAND BIOLABS 566 20.2.22.1 Business overview 566 20.2.22.2 Products/Services offered 566 20.2.22.3 Recent developments 569 20.2.22.3.1 Product launches 569 20.2.22.3.2 Deals 570 20.2.23 PROMEGA CORPORATION 571 20.2.23.1 Business overview 571 20.2.23.2 Products/Services offered 571 20.2.23.3 Recent developments 572 20.2.23.3.1 Product launches 572 20.2.23.3.2 Other developments 573 20.3 OTHER PLAYERS 574 20.3.1 CREATIVE BIOGENE 574 20.3.2 NOVOGENE CO., LTD. 575 20.3.3 HELIX, INC. 576 20.3.4 PHALANX BIOTECH GROUP 577 20.3.5 POLARIS GENOMICS 578   21 APPENDIX 579 21.1 DISCUSSION GUIDE 579 21.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 584 21.3 CUSTOMIZATION OPTIONS 586 21.4 RELATED REPORTS 587 21.5 AUTHOR DETAILS 588
圖表清單 List of Tables & Figures
TABLE 1 GENOMICS MARKET: INCLUSIONS & EXCLUSIONS 46 TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS 59 TABLE 3 GENOMICS MARKET: RISK ANALYSIS 62 TABLE 4 GENOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 75 TABLE 5 GENOMICS MARKET: IMPACT OF PORTER’S FIVE FORCES 85 TABLE 6 GENOMICS MARKET: ROLE IN ECOSYSTEM 89 TABLE 7 GENOMICS MARKET: EMERGING BUSINESS MODELS & TARGET SEGMENTS 90 TABLE 8 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD) 92 TABLE 9 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD) 93 TABLE 10 AVERAGE SELLING PRICE OF SERVICES, BY KEY PLAYER, 2024 (USD) 94 TABLE 11 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024 (USD) 95 TABLE 12 IMPORT VALUE FOR HS CODE 3822, 2020–2024 (USD THOUSAND) 96 TABLE 13 IMPORT VOLUME FOR HS CODE 3822, 2020–2024 (TONS) 97 TABLE 14 IMPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND) 98 TABLE 15 IMPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS) 98 TABLE 16 EXPORT VALUE FOR HS CODE 3822, BY COUNTRY, 2019–2023 (USD THOUSAND) 99 TABLE 17 EXPORT VOLUME FOR HS CODE 3822, BY COUNTRY, 2019–2023 (TONS) 100 TABLE 18 EXPORT VALUE FOR HS CODE 902789, 2022–2024 (USD THOUSAND) 101 TABLE 19 EXPORT VOLUME FOR HS CODE 902789, 2022–2024 (UNITS) 102 TABLE 20 GENOMICS MARKET: KEY CONFERENCES AND EVENTS, 2026 102 TABLE 21 SNP ARRAY IDENTIFIED INHERITED GENETIC DISORDER CONTRIBUTING TO IVF FAILURES 106 TABLE 22 LONG-READ WHOLE GENOME SEQUENCING WAS USED IN CHILDREN'S MERCY KANSAS CITY 107 TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES 108 TABLE 24 GENOMICS MARKET: INDICATIVE LIST OF PATENTS, 2025 119 TABLE 25 CASE STUDIES OF AI IMPLEMENTATION IN GENOMICS MARKET 123 TABLE 26 CLIENT’S READINESS TO ADOPT GENERATIVE AI IN GENOMICS 124 TABLE 27 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 125 TABLE 28 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 125 TABLE 29 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 126 TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 127 TABLE 31 US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION 128 TABLE 32 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 128 TABLE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%) 132 TABLE 34 KEY BUYING CRITERIA, BY END USER 133 TABLE 35 GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 137 TABLE 36 GENOMICS PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 37 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 38 EUROPE: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 39 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 40 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 41 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 42 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 43 GENOMICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 44 NORTH AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 45 EUROPE: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 46 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 47 LATIN AMERICA: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 48 MIDDLE EAST: GENOMICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 142 TABLE 49 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 50 GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 51 GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 147 TABLE 52 NORTH AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 53 EUROPE: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 54 ASIA PACIFIC: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 55 LATIN AMERICA: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 56 MIDDLE EAST: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 57 GCC COUNTRIES: GENOMICS REAGENTS, KITS, AND CONSUMABLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 58 GENOMICS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 59 NORTH AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 60 EUROPE: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 61 ASIA PACIFIC: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 62 LATIN AMERICA: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 63 MIDDLE EAST: GENOMICS INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 64 GCC COUNTRIES: GENOMICS INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 65 GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION) 155 TABLE 66 NORTH AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 67 EUROPE: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 68 ASIA PACIFIC: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 69 LATIN AMERICA: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 70 MIDDLE EAST: GENOMICS BIOINFORMATICS TOOLS MARKET, BY REGION, 2023–2030 (USD MILLION) 157 TABLE 71 GCC COUNTRIES: GENOMICS BIOINFORMATICS TOOLS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 72 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 159 TABLE 73 SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 160 TABLE 74 NORTH AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 75 EUROPE: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 76 ASIA PACIFIC: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 77 LATIN AMERICA: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 78 MIDDLE EAST: SEQUENCING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 79 GCC COUNTRIES: SEQUENCING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 80 SEQUENCING PLATFORMS MARKET, BY TYPE, 2023–2030 (UNITS) 163 TABLE 81 PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 164 TABLE 82 NORTH AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 83 EUROPE: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 84 ASIA PACIFIC: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 85 LATIN AMERICA: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 86 MIDDLE EAST: PCR PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 87 GCC COUNTRIES: PCR PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 88 GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 167 TABLE 89 NORTH AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 90 EUROPE: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 91 ASIA PACIFIC: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 92 LATIN AMERICA: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 93 MIDDLE EAST: GENE EDITING PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 169 TABLE 94 GCC COUNTRIES: GENE EDITING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 95 FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 96 NORTH AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 97 EUROPE: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 98 ASIA PACIFIC: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 99 LATIN AMERICA: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 100 MIDDLE EAST: FLOW CYTOMETRY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 101 GCC COUNTRIES: FLOW CYTOMETRY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 102 FLOW CYTOMETRY INSTRUMENTS MARKET, BY TYPE, 2023–2030 (UNITS) 174 TABLE 103 MICROARRAY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 175 TABLE 104 NORTH AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 175 TABLE 105 EUROPE: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 106 ASIA PACIFIC: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 107 LATIN AMERICA: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 108 MIDDLE EAST: MICROARRAY PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 109 GCC COUNTRIES: MICROARRAY PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 110 IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 111 NORTH AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 112 EUROPE: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 113 ASIA PACIFIC: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 180 TABLE 114 LATIN AMERICA: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 115 MIDDLE EAST: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 116 GCC COUNTRIES: IN SITU HYBRIDIZATION PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 117 GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 182 TABLE 118 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 119 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 120 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 121 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 122 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 123 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 124 GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 125 GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 126 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 127 EUROPE: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 128 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 129 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 130 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 131 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 132 GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 193 TABLE 133 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 193 TABLE 134 EUROPE: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 135 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 136 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 137 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 195 TABLE 138 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 195 TABLE 139 GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 140 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 141 EUROPE: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 142 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 143 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 144 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 199 TABLE 145 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 199 TABLE 146 GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 201 TABLE 147 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 201 TABLE 148 EUROPE: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 149 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 150 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 151 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR CROS, BY REGION, 2023–2030 (USD MILLION) 203 TABLE 152 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR CROS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 153 GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 204 TABLE 154 NORTH AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 204 TABLE 155 EUROPE: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 156 ASIA PACIFIC: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 157 LATIN AMERICA: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 158 MIDDLE EAST: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 206 TABLE 159 GCC COUNTRIES: GENOMICS PRODUCTS MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 206 TABLE 160 GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 161 GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 209 TABLE 162 NORTH AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 163 EUROPE: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 164 ASIA PACIFIC: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 165 LATIN AMERICA: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 166 MIDDLE EAST: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 211 TABLE 167 GCC COUNTRIES: GENOMIC PROFILING & SEQUENCING SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 168 SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 212 TABLE 169 NORTH AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 170 EUROPE: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 171 ASIA PACIFIC: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 172 LATIN AMERICA: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 173 MIDDLE EAST: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 214 TABLE 174 GCC COUNTRIES: SAMPLE PREPARATION & LIBRARY PREPARATION SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 175 BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 216 TABLE 176 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 177 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 178 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 179 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 180 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 218 TABLE 181 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 218 TABLE 182 GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 220 TABLE 183 GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION) 221 TABLE 184 NORTH AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 221 TABLE 185 EUROPE: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 186 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 187 LATIN AMERICA: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 188 MIDDLE EAST: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY REGION, 2023–2030 (USD MILLION) 223 TABLE 189 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR HOSPITALS, DIAGNOSTIC LABORATORIES, AND CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 223 TABLE 190 GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 224 TABLE 191 NORTH AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 192 EUROPE: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 225 TABLE 193 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 194 LATIN AMERICA: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 195 MIDDLE EAST: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 196 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 197 GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 198 NORTH AMERICA: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 228 TABLE 199 EUROPE: GENOMICS SERVICE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 200 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 201 LATIN AMERICA: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 202 MIDDLE EAST: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023–2030 (USD MILLION) 230 TABLE 203 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2023–2030 (USD MILLION) 230 TABLE 204 GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 232 TABLE 205 NORTH AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 206 EUROPE: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 207 ASIA PACIFIC: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 233 TABLE 208 LATIN AMERICA: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 209 MIDDLE EAST: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 234 TABLE 210 GCC COUNTRIES: GENOMICS SERVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 211 GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 236 TABLE 212 GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 237 TABLE 213 NORTH AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 214 EUROPE: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 215 ASIA PACIFIC: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 238 TABLE 216 LATIN AMERICA: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 217 MIDDLE EAST: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2023–2030 (USD MILLION) 239 TABLE 218 GCC COUNTRIES: GENOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2023–2030 (USD MILLION) 239 TABLE 219 GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 220 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 221 EUROPE: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 241 TABLE 222 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 223 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 242 TABLE 224 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 242 TABLE 225 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 226 GENOMICS MARKET FOR DIAGNOSTICS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 227 GRANTS, BY CANCER TYPE (AS OF OCTOBER 2025) 244 TABLE 228 GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 245 TABLE 229 NORTH AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 245 TABLE 230 EUROPE: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 231 ASIA PACIFIC: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 246 TABLE 232 LATIN AMERICA: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 233 MIDDLE EAST: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION) 247 TABLE 234 GCC COUNTRIES: GENOMICS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 235 GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION) 248 TABLE 236 NORTH AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 237 EUROPE: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 249 TABLE 238 ASIA PACIFIC: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 239 LATIN AMERICA: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 250 TABLE 240 MIDDLE EAST: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2023–2030 (USD MILLION) 250 TABLE 241 GCC COUNTRIES: GENOMICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 242 GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION) 252 TABLE 243 NORTH AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION) 252 TABLE 244 EUROPE: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 245 ASIA PACIFIC: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 246 LATIN AMERICA: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 247 MIDDLE EAST: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION, 2023–2030 (USD MILLION) 254 TABLE 248 GCC COUNTRIES: GENOMICS MARKET FOR REPRODUCTIVE HEALTH, BY COUNTRY, 2023–2030 (USD MILLION) 254 TABLE 249 GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 255 TABLE 250 NORTH AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 255 TABLE 251 EUROPE: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 252 ASIA PACIFIC: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 253 LATIN AMERICA: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 254 MIDDLE EAST: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 257 TABLE 255 GCC COUNTRIES: GENOMICS MARKET FOR OTHER DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 257 TABLE 256 GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 258 TABLE 257 NORTH AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 258 EUROPE: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 259 ASIA PACIFIC: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 260 TABLE 260 LATIN AMERICA: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 260 TABLE 261 MIDDLE EAST: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2023–2030 (USD MILLION) 260 TABLE 262 GCC COUNTRIES: GENOMICS MARKET FOR AGRICULTURE & ANIMAL RESEARCH, BY COUNTRY, 2023–2030 (USD MILLION) 261 TABLE 263 GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 261 TABLE 264 NORTH AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 265 EUROPE: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 262 TABLE 266 ASIA PACIFIC: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 263 TABLE 267 LATIN AMERICA: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 263 TABLE 268 MIDDLE EAST: GENOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 263 TABLE 269 GCC COUNTRIES: GENOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 264 TABLE 270 GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 266 TABLE 271 GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023–2030 (USD MILLION) 267 TABLE 272 NORTH AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 273 EUROPE: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 274 ASIA PACIFIC: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 268 TABLE 275 LATIN AMERICA: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 276 MIDDLE EAST: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY REGION, 2023–2030 (USD MILLION) 269 TABLE 277 GCC COUNTRIES: GENOMICS MARKET FOR FUNCTIONAL GENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 269 TABLE 278 GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023–2030 (USD MILLION) 270 TABLE 279 NORTH AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 280 EUROPE: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 271 TABLE 281 ASIA PACIFIC: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 282 LATIN AMERICA: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 272 TABLE 283 MIDDLE EAST: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2023–2030 (USD MILLION) 272 TABLE 284 GCC COUNTRIES: GENOMICS MARKET FOR BIOMARKER DISCOVERY, BY COUNTRY, 2023–2030 (USD MILLION) 273 TABLE 285 GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023–2030 (USD MILLION) 274 TABLE 286 NORTH AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 274 TABLE 287 EUROPE: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 288 ASIA PACIFIC: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 275 TABLE 289 LATIN AMERICA: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 290 MIDDLE EAST: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY REGION, 2023–2030 (USD MILLION) 276 TABLE 291 GCC COUNTRIES: GENOMICS MARKET FOR PATHWAY ANALYSIS, BY COUNTRY, 2023–2030 (USD MILLION) 276 TABLE 292 GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023–2030 (USD MILLION) 278 TABLE 293 NORTH AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 278 TABLE 294 EUROPE: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 295 ASIA PACIFIC: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 279 TABLE 296 LATIN AMERICA: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 297 MIDDLE EAST: GENOMICS MARKET FOR EPIGENOMICS, BY REGION, 2023–2030 (USD MILLION) 280 TABLE 298 GCC COUNTRIES: GENOMICS MARKET FOR EPIGENOMICS, BY COUNTRY, 2023–2030 (USD MILLION) 280 TABLE 299 GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023–2030 (USD MILLION) 282 TABLE 300 NORTH AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 282 TABLE 301 EUROPE: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 283 TABLE 302 ASIA PACIFIC: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 283 TABLE 303 LATIN AMERICA: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 304 MIDDLE EAST: GENOMICS MARKET FOR OTHER STUDY TYPES, BY REGION, 2023–2030 (USD MILLION) 284 TABLE 305 GCC COUNTRIES: GENOMICS MARKET FOR OTHER STUDY TYPES, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 306 GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION) 286 TABLE 307 NORTH AMERICA: KEY MACROINDICATORS 288 TABLE 308 NORTH AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 288 TABLE 309 NORTH AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 288 TABLE 310 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 311 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 289 TABLE 312 NORTH AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 313 NORTH AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 290 TABLE 314 NORTH AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 291 TABLE 315 NORTH AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 291 TABLE 316 NORTH AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 292 TABLE 317 NORTH AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 292 TABLE 318 US: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 294 TABLE 319 US: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 320 US: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 294 TABLE 321 US: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 295 TABLE 322 US: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 323 US: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 296 TABLE 324 US: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 325 US: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 297 TABLE 326 US: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 297 TABLE 327 CANADA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 299 TABLE 328 CANADA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 329 CANADA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 299 TABLE 330 CANADA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 300 TABLE 331 CANADA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 332 CANADA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 301 TABLE 333 CANADA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 334 CANADA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 302 TABLE 335 CANADA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 302 TABLE 336 EUROPE: KEY MACROINDICATORS 303 TABLE 337 EUROPE: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 304 TABLE 338 EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 304 TABLE 339 EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 304 TABLE 340 EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 305 TABLE 341 EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 305 TABLE 342 EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 343 EUROPE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 306 TABLE 344 EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 345 EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 307 TABLE 346 EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 308 TABLE 347 GERMANY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 309 TABLE 348 GERMANY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 349 GERMANY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 310 TABLE 350 GERMANY: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 310 TABLE 351 GERMANY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 352 GERMANY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 311 TABLE 353 GERMANY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 354 GERMANY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 312 TABLE 355 GERMANY: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 313 TABLE 356 UK: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 314 TABLE 357 UK: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 358 UK: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 315 TABLE 359 UK: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 315 TABLE 360 UK: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 361 UK: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 316 TABLE 362 UK: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 363 UK: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 317 TABLE 364 UK: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 318 TABLE 365 FRANCE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 319 TABLE 366 FRANCE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 367 FRANCE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 319 TABLE 368 FRANCE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 320 TABLE 369 FRANCE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 370 FRANCE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 321 TABLE 371 FRANCE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 372 FRANCE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 322 TABLE 373 FRANCE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 374 ITALY: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 323 TABLE 375 ITALY: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 376 ITALY: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 324 TABLE 377 ITALY: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 325 TABLE 378 ITALY: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 379 ITALY: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 326 TABLE 380 ITALY: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 381 ITALY: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 327 TABLE 382 ITALY: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 327 TABLE 383 SPAIN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 328 TABLE 384 SPAIN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 385 SPAIN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 329 TABLE 386 SPAIN: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 329 TABLE 387 SPAIN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 388 SPAIN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 330 TABLE 389 SPAIN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 390 SPAIN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 331 TABLE 391 SPAIN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 332 TABLE 392 REST OF EUROPE: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 333 TABLE 393 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 394 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 334 TABLE 395 REST OF EUROPE: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 334 TABLE 396 REST OF EUROPE: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 335 TABLE 397 REST OF EUROPE: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 335 TABLE 398 REST OF EUROPE: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 399 REST OF EUROPE: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 336 TABLE 400 REST OF EUROPE: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 337 TABLE 401 ASIA PACIFIC: KEY MACROINDICATORS 339 TABLE 402 ASIA PACIFIC: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 339 TABLE 403 ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 340 TABLE 404 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 405 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 340 TABLE 406 ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 341 TABLE 407 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 341 TABLE 408 ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 342 TABLE 409 ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 410 ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 343 TABLE 411 ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 343 TABLE 412 CHINA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 344 TABLE 413 CHINA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 414 CHINA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 345 TABLE 415 CHINA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 345 TABLE 416 CHINA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 417 CHINA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 346 TABLE 418 CHINA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 347 TABLE 419 CHINA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 347 TABLE 420 CHINA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 348 TABLE 421 JAPAN: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 349 TABLE 422 JAPAN: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 423 JAPAN: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 349 TABLE 424 JAPAN: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 350 TABLE 425 JAPAN: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 426 JAPAN: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 351 TABLE 427 JAPAN: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 428 JAPAN: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 352 TABLE 429 JAPAN: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 352 TABLE 430 INDIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 353 TABLE 431 INDIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 353 TABLE 432 INDIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 354 TABLE 433 INDIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 354 TABLE 434 INDIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 435 INDIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 355 TABLE 436 INDIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 437 INDIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 356 TABLE 438 INDIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 357 TABLE 439 AUSTRALIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 358 TABLE 440 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 441 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 358 TABLE 442 AUSTRALIA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 359 TABLE 443 AUSTRALIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 444 AUSTRALIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 360 TABLE 445 AUSTRALIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 360 TABLE 446 AUSTRALIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 361 TABLE 447 AUSTRALIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 361 TABLE 448 SOUTH KOREA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 362 TABLE 449 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 450 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 363 TABLE 451 SOUTH KOREA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 363 TABLE 452 SOUTH KOREA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 453 SOUTH KOREA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 364 TABLE 454 SOUTH KOREA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 455 SOUTH KOREA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 365 TABLE 456 SOUTH KOREA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 366 TABLE 457 REST OF ASIA PACIFIC: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 367 TABLE 458 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 367 TABLE 459 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 368 TABLE 460 REST OF ASIA PACIFIC: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 368 TABLE 461 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 462 REST OF ASIA PACIFIC: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 369 TABLE 463 REST OF ASIA PACIFIC: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 464 REST OF ASIA PACIFIC: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 370 TABLE 465 REST OF ASIA PACIFIC: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 371 TABLE 466 LATIN AMERICA: KEY MACROINDICATORS 372 TABLE 467 LATIN AMERICA: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 372 TABLE 468 LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 373 TABLE 469 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 373 TABLE 470 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 373 TABLE 471 LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 374 TABLE 472 LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 374 TABLE 473 LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 375 TABLE 474 LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 375 TABLE 475 LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 376 TABLE 476 LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 376 TABLE 477 BRAZIL: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 377 TABLE 478 BRAZIL: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 377 TABLE 479 BRAZIL: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 378 TABLE 480 BRAZIL: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 378 TABLE 481 BRAZIL: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 379 TABLE 482 BRAZIL: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 379 TABLE 483 BRAZIL: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 380 TABLE 484 BRAZIL: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 380 TABLE 485 BRAZIL: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 381 TABLE 486 MEXICO: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 382 TABLE 487 MEXICO: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 382 TABLE 488 MEXICO: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 382 TABLE 489 MEXICO: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 383 TABLE 490 MEXICO: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 383 TABLE 491 MEXICO: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 384 TABLE 492 MEXICO: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 384 TABLE 493 MEXICO: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 385 TABLE 494 MEXICO: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 385 TABLE 495 REST OF LATIN AMERICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 386 TABLE 496 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 386 TABLE 497 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 387 TABLE 498 REST OF LATIN AMERICA: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 387 TABLE 499 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 388 TABLE 500 REST OF LATIN AMERICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 388 TABLE 501 REST OF LATIN AMERICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 389 TABLE 502 REST OF LATIN AMERICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 389 TABLE 503 REST OF LATIN AMERICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 390 TABLE 504 MIDDLE EAST: KEY MACROINDICATORS 391 TABLE 505 MIDDLE EAST: GENOMICS MARKET, BY REGION, 2023–2030 (USD MILLION) 391 TABLE 506 MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 391 TABLE 507 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 392 TABLE 508 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 392 TABLE 509 MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 393 TABLE 510 MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 393 TABLE 511 MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 394 TABLE 512 MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 394 TABLE 513 MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 395 TABLE 514 MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 395 TABLE 515 GCC COUNTRIES: GENOMICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 396 TABLE 516 GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 396 TABLE 517 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 396 TABLE 518 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 397 TABLE 519 GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 397 TABLE 520 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 398 TABLE 521 GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 398 TABLE 522 GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 399 TABLE 523 GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 399 TABLE 524 GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 400 TABLE 525 SAUDI ARABIA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 401 TABLE 526 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 401 TABLE 527 SAUDI ARABIA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 401 TABLE 528 SAUDI ARABIA: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION) 402 TABLE 529 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 402 TABLE 530 SAUDI ARABIA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 403 TABLE 531 SAUDI ARABIA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 403 TABLE 532 SAUDI ARABIA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 404 TABLE 533 SAUDI ARABIA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 404 TABLE 534 UNITED ARAB EMIRATES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 405 TABLE 535 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 405 TABLE 536 UNITED ARAB EMIRATES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 406 TABLE 537 UNITED ARAB EMIRATES: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION) 406 TABLE 538 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 407 TABLE 539 UNITED ARAB EMIRATES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 407 TABLE 540 UNITED ARAB EMIRATES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 408 TABLE 541 UNITED ARAB EMIRATES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 408 TABLE 542 UNITED ARAB EMIRATES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 409 TABLE 543 REST OF GCC COUNTRIES: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 410 TABLE 544 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 410 TABLE 545 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 411 TABLE 546 REST OF GCC COUNTRIES: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 411 TABLE 547 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 412 TABLE 548 REST OF GCC COUNTRIES: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 412 TABLE 549 REST OF GCC COUNTRIES: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 413 TABLE 550 REST OF GCC COUNTRIES: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 413 TABLE 551 REST OF GCC COUNTRIES: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 414 TABLE 552 REST OF MIDDLE EAST: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 415 TABLE 553 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 415 TABLE 554 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 415 TABLE 555 REST OF MIDDLE EAST: GENOMICS PRODUCTS MARKET, BY END USER, 2023–2030 (USD MILLION) 416 TABLE 556 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 416 TABLE 557 REST OF MIDDLE EAST: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 417 TABLE 558 REST OF MIDDLE EAST: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 417 TABLE 559 REST OF MIDDLE EAST: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 418 TABLE 560 REST OF MIDDLE EAST: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 418 TABLE 561 AFRICA: KEY MACROINDICATORS 419 TABLE 562 AFRICA: GENOMICS MARKET, BY OFFERING, 2023–2030 (USD MILLION) 420 TABLE 563 AFRICA: GENOMICS PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 420 TABLE 564 AFRICA: GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 420 TABLE 565 AFRICA: GENOMICS PRODUCT MARKET, BY END USER, 2023–2030 (USD MILLION) 421 TABLE 566 AFRICA: GENOMICS SERVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 421 TABLE 567 AFRICA: GENOMICS MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 422 TABLE 568 AFRICA: GENOMICS MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2023–2030 (USD MILLION) 422 TABLE 569 AFRICA: GENOMICS MARKET, BY STUDY TYPE, 2023–2030 (USD MILLION) 423 TABLE 570 AFRICA: GENOMICS SERVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 423 TABLE 571 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN GENOMICS MARKET, JANUARY 2022−OCTOBER 2025 425 TABLE 572 GENOMICS PRODUCTS MARKET: DEGREE OF COMPETITION 428 TABLE 573 MARKET RANK OF KEY PLAYERS IN GENOMICS SERVICES MARKET (2024) 429 TABLE 574 GENOMICS MARKET: REGION FOOTPRINT 434 TABLE 575 GENOMICS MARKET: PRODUCT FOOTPRINT 435 TABLE 576 GENOMICS MARKET: APPLICATION FOOTPRINT 436 TABLE 577 GENOMICS MARKET: TECHNOLOGY FOOTPRINT 437 TABLE 578 GENOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 440 TABLE 579 GENOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS 440 TABLE 580 GENOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2022—OCTOBER 2025 442 TABLE 581 GENOMICS MARKET: DEALS, JANUARY 2022—OCTOBER 2025 443 TABLE 582 GENOMICS MARKET: EXPANSIONS, JANUARY 2022—OCTOBER 2025 443 TABLE 583 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 445 TABLE 584 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 446 TABLE 585 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 451 TABLE 586 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–OCTOBER 2025 454 TABLE 587 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025 455 TABLE 588 ILLUMINA, INC.: COMPANY OVERVIEW 457 TABLE 589 ILLUMINA, INC.: PRODUCTS/SERVICES OFFERED 458 TABLE 590 ILLUMINA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 461 TABLE 591 ILLUMINA, INC.: DEALS, JANUARY 2022–OCTOBER 2025 463 TABLE 592 ILLUMINA, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025 465 TABLE 593 ILLUMINA, INC.: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 465 TABLE 594 DANAHER CORPORATION: COMPANY OVERVIEW 467 TABLE 595 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED 468 TABLE 596 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 470 TABLE 597 DANAHER CORPORATION: DEALS, JANUARY 2022–OCTOBER 2025 471 TABLE 598 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–OCTOBER 2025 472 TABLE 599 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 474 TABLE 600 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED 475 TABLE 601 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 477 TABLE 602 F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2022–OCTOBER 2025 478 TABLE 603 F. HOFFMANN-LA ROCHE LTD.: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 479 TABLE 604 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 480 TABLE 605 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED 481 TABLE 606 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 484 TABLE 607 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025 485 TABLE 608 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025 486 TABLE 609 QIAGEN: COMPANY OVERVIEW 488 TABLE 610 QIAGEN: PRODUCTS/SERVICES OFFERED 489 TABLE 611 QIAGEN: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 492 TABLE 612 QIAGEN: DEALS, JANUARY 2022–OCTOBER 2025 493 TABLE 613 QIAGEN: EXPANSIONS, JANUARY 2022–OCTOBER 2025 495 TABLE 614 REVVITY: COMPANY OVERVIEW 496 TABLE 615 REVVITY: PRODUCTS/SERVICES OFFERED 497 TABLE 616 REVVITY: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 500 TABLE 617 REVVITY: DEALS, JANUARY 2022–OCTOBER 2025 501 TABLE 618 REVVITY: EXPANSIONS, JANUARY 2022–OCTOBER 2025 501 TABLE 619 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW 502 TABLE 620 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED 503 TABLE 621 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICE LAUNCHES, JANUARY 2022–OCTOBER 2025 504 TABLE 622 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS, JANUARY 2022–OCTOBER 2025 505 TABLE 623 LABORATORY CORPORATION OF AMERICA HOLDINGS: EXPANSIONS, JANUARY 2022–OCTOBER 2025 505 TABLE 624 IQVIA INC.: COMPANY OVERVIEW 506 TABLE 625 IQVIA INC.: SERVICES OFFERED 507 TABLE 626 IQVIA INC.: DEALS, JANUARY 2022–OCTOBER 2025 508 TABLE 627 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 509 TABLE 628 CHARLES RIVER LABORATORIES: SERVICES OFFERED 510 TABLE 629 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 511 TABLE 630 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED 512 TABLE 631 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 514 TABLE 632 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2022–OCTOBER 2025 515 TABLE 633 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 516 TABLE 634 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES OFFERED 517 TABLE 635 EUROFINS SCIENTIFIC: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 518 TABLE 636 EUROFINS SCIENTIFIC: DEALS, JANUARY 2022–OCTOBER 2025 518 TABLE 637 PACBIO: COMPANY OVERVIEW 519 TABLE 638 PACBIO: PRODUCTS/SERVICES OFFERED 520 TABLE 639 PACBIO: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 522 TABLE 640 PACBIO: DEALS, JANUARY 2022–OCTOBER 2025 523 TABLE 641 PACBIO: EXPANSIONS, JANUARY 2022–OCTOBER 2025 525 TABLE 642 PACBIO: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 525 TABLE 643 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY OVERVIEW 526 TABLE 644 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCTS/SERVICES OFFERED 527 TABLE 645 OXFORD NANOPORE TECHNOLOGIES PLC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 529 TABLE 646 OXFORD NANOPORE TECHNOLOGIES PLC.: DEALS, JANUARY 2022–OCTOBER 2025 529 TABLE 647 OXFORD NANOPORE TECHNOLOGIES PLC.: EXPANSIONS, JANUARY 2022–OCTOBER 2025 532 TABLE 648 TAKARA BIO INC.: COMPANY OVERVIEW 533 TABLE 649 TAKARA BIO INC.: PRODUCTS/SERVICES OFFERED 534 TABLE 650 TAKARA BIO INC.: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 538 TABLE 651 TAKARA BIO INC.: DEALS, JANUARY 2022–OCTOBER 2025 538 TABLE 652 BGI GROUP: COMPANY OVERVIEW 539 TABLE 653 BGI GROUP: PRODUCTS/SERVICES OFFERED 539 TABLE 654 BGI GROUP: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 543 TABLE 655 BGI GROUP: DEALS, JANUARY 2022–OCTOBER 2025 544 TABLE 656 BGI GROUP: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 545 TABLE 657 EPPENDORF SE: COMPANY OVERVIEW 546 TABLE 658 EPPENDORF SE: PRODUCTS/SERVICES OFFERED 547 TABLE 659 EPPENDORF SE: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 548 TABLE 660 MERCK KGAA: COMPANY OVERVIEW 549 TABLE 661 MERCK KGAA: PRODUCTS/SERVICES OFFERED 550 TABLE 662 MERCK KGAA: DEALS, JANUARY 2022–OCTOBER 2025 551 TABLE 663 MERCK KGAA: EXPANSIONS, JANUARY 2022–OCTOBER 2025 552 TABLE 664 BD: COMPANY OVERVIEW 553 TABLE 665 BD: PRODUCTS/SERVICES OFFERED 554 TABLE 666 BD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–OCTOBER 2025 556 TABLE 667 BD: DEALS, JANUARY 2022–OCTOBER 2025 557 TABLE 668 ABBOTT: COMPANY OVERVIEW 558 TABLE 669 ABBOTT: PRODUCTS/SERVICES OFFERED 559 TABLE 670 10X GENOMICS: COMPANY OVERVIEW 562 TABLE 671 10X GENOMICS: PRODUCTS/SERVICES OFFERED 563 TABLE 672 10X GENOMICS: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 565 TABLE 673 NEW ENGLAND BIOLABS: COMPANY OVERVIEW 566 TABLE 674 NEW ENGLAND BIOLABS: PRODUCTS/SERVICES OFFERED 566 TABLE 675 NEW ENGLAND BIOLABS: PRODUCT LAUNCHES, JANUARY 2021– SEPTEMBER 2024 569 TABLE 676 NEW ENGLAND BIOLABS: DEALS, JANUARY 2022–OCTOBER 2025 570 TABLE 677 PROMEGA CORPORATION: COMPANY OVERVIEW 571 TABLE 678 PROMEGA CORPORATION: PRODUCTS/SERVICES OFFERED 571 TABLE 679 PROMEGA CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–OCTOBER 2025 572 TABLE 680 PROMEGA CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–OCTOBER 2025 573 TABLE 681 CREATIVE BIOGENE: COMPANY OVERVIEW 574 TABLE 682 NOVOGENE CO., LTD.: COMPANY OVERVIEW 575 TABLE 683 HELIX, INC.: COMPANY OVERVIEW 576 TABLE 684 PHALANX BIOTECH GROUP: COMPANY OVERVIEW 577 TABLE 685 POLARIS GENOMICS: COMPANY OVERVIEW 578 FIGURE 1 GENOMICS MARKET SEGMENTATION & REGIONAL SCOPE 45 FIGURE 2 GENOMICS MARKET: YEARS CONSIDERED 47 FIGURE 3 GENOMICS MARKET: RESEARCH DESIGN 49 FIGURE 4 GENOMICS MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS) 51 FIGURE 5 GLOBAL GENOMICS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024 52 FIGURE 6 GLOBAL GENOMICS MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM–UP APPROACH), 2024 53 FIGURE 7 GENOMICS MARKET SIZE VALIDATION FROM INDUSTRY EXPERTS 54 FIGURE 8 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 55 FIGURE 9 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY (COMPANY REVENUE ANALYSIS) 56 FIGURE 10 GLOBAL GENOMICS MARKET: CAGR PROJECTIONS (2025–2030) 58 FIGURE 11 DATA TRIANGULATION 60 FIGURE 12 GENOMICS MARKET, BY OFFERING, 2025 VS. 2030 (USD MILLION) 63 FIGURE 13 GENOMICS PRODUCTS MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 64 FIGURE 14 GENOMICS PRODUCTS MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 64 FIGURE 15 GENOMICS PRODUCTS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 65 FIGURE 16 GENOMICS SERVICES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 66 FIGURE 17 GENOMICS SERVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 66 FIGURE 18 GENOMICS MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 67 FIGURE 19 GENOMICS MARKET, BY STUDY TYPE, 2025 VS. 2030 (USD MILLION) 68 FIGURE 20 REGIONAL SNAPSHOT OF GENOMICS MARKET 69 FIGURE 21 INCREASING GOVERNMENT FUNDING FOR GENOMICS PROJECTS TO PROPEL MARKET GROWTH 71 FIGURE 22 US AND DRUG DISCOVERY & DEVELOPMENT COMMANDED LARGEST MARKET SHARES IN 2024 72 FIGURE 23 CHINA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 73 FIGURE 24 GENOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 74 FIGURE 25 BURDEN OF HIV INFECTIONS, BY REGION, 2024 77 FIGURE 26 GENOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 84 FIGURE 27 GROWTH OF GLOBAL GDP FROM 2020 TO 2024, WITH FORECASTS UNTIL 2030 87 FIGURE 28 GENOMICS MARKET: VALUE CHAIN ANALYSIS 88 FIGURE 29 GENOMICS MARKET ECOSYSTEM 89 FIGURE 30 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY KEY PLAYER, 2022–2024 (USD) 93 FIGURE 31 AVERAGE SELLING PRICE TREND OF CONSUMABLES, BY KEY PLAYER, 2022–2024 (USD) 94 FIGURE 32 AVERAGE SELLING PRICE TREND OF INSTRUMENTS, BY REGION, 2022–2024 (USD) 96 FIGURE 33 REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN GENOMICS MARKET 103 FIGURE 34 PE/VC INVESTMENTS IN LIFE SCIENCES SPLIT BETWEEN PHARMACEUTICALS AND HEALTHCARE 105 FIGURE 35 TOP APPLICANTS/OWNERS (COMPANIES) FOR GENOMICS PATENTS, 2014–2024 118 FIGURE 36 IMPACT OF AI/GEN AI ON GENOMICS MARKET 122 FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 132 FIGURE 38 KEY BUYING CRITERIA, BY END USER 133 FIGURE 39 NORTH AMERICA: GENOMICS MARKET SNAPSHOT 287 FIGURE 40 ASIA PACIFIC: GENOMICS MARKET SNAPSHOT 338 FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN GENOMICS MARKET, 2020–2024 (USD BILLION) 427 FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN GENOMICS PRODUCTS MARKET (2024) 428 FIGURE 43 GENOMICS MARKET: BRAND/PRODUCT COMPARISON 430 FIGURE 44 GENOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 432 FIGURE 45 GENOMICS MARKET: COMPANY FOOTPRINT 433 FIGURE 46 GENOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 439 FIGURE 47 EV/EBITDA OF KEY VENDORS 441 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 441 FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2024) 446 FIGURE 50 ILLUMINA, INC.: COMPANY SNAPSHOT (2024) 458 FIGURE 51 DANAHER CORPORATION: COMPANY SNAPSHOT (2024) 468 FIGURE 52 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2024) 475 FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2024) 481 FIGURE 54 QIAGEN: COMPANY SNAPSHOT (2024) 489 FIGURE 55 REVVITY: COMPANY SNAPSHOT (2024) 497 FIGURE 56 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2024) 503 FIGURE 57 IQVIA INC.: COMPANY SNAPSHOT (2024) 507 FIGURE 58 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2024) 510 FIGURE 59 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2024) 512 FIGURE 60 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2024) 516 FIGURE 61 PACBIO: COMPANY SNAPSHOT (2024) 520 FIGURE 62 OXFORD NANOPORE TECHNOLOGIES PLC.: COMPANY SNAPSHOT (2024) 527 FIGURE 63 TAKARA BIO INC.: COMPANY SNAPSHOT (2024) 534 FIGURE 64 EPPENDORF SE: COMPANY SNAPSHOT (2024) 547 FIGURE 65 MERCK KGAA: COMPANY SNAPSHOT (2024) 550 FIGURE 66 BD: COMPANY SNAPSHOT (2024) 554 FIGURE 67 ABBOTT: COMPANY SNAPSHOT (2024) 559 FIGURE 68 10X GENOMICS: COMPANY SNAPSHOT (2024) 563

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們